Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-094152
Filing Date
2023-04-06
Accepted
2023-04-06 17:08:06
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d493706ds3.htm S-3 451583
2 EX-1.2 d493706dex12.htm EX-1.2 192403
3 EX-4.5 d493706dex45.htm EX-4.5 319256
4 EX-4.7 d493706dex47.htm EX-4.7 98657
5 EX-4.8 d493706dex48.htm EX-4.8 110874
6 EX-4.9 d493706dex49.htm EX-4.9 95559
7 EX-5.1 d493706dex51.htm EX-5.1 29425
8 EX-23.1 d493706dex231.htm EX-23.1 1568
9 EX-FILING FEES d493706dexfilingfees.htm EX-FILING FEES 46617
10 GRAPHIC g493706g0404155722871.jpg GRAPHIC 2413
11 GRAPHIC g493706g42t60.jpg GRAPHIC 35431
  Complete submission text file 0001193125-23-094152.txt   1393495
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271174 | Film No.: 23807026
SIC: 2834 Pharmaceutical Preparations